SLC3A2 and colorectal carcinoma: Next, the effect of the anti-CD98hc-DM1 ADC was investigated in two in vivo models of colon cancer, one derived from HT29 cells xenografted in nude mice, and the other derived from tissue implanted from a patient with CRC which was established as a PDX.